FDA Grants Fast Track Designation to Genzyme ’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease
Research and Markets: Global Gaucher Disease Market 2015-2019: Key Players Include Actelion Pharmaceuticals, Genzyme , Pfizer & Shire
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
Who's in front heading 'round the bend?
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.
Many funds' fortunes have turned amid these stocks' volatility.
Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.